Federal Register Notice: CDER will assign new numbers to a group of investigational new drug applications because the 2003 consolidation of INDS transferred from CBER with CDER resulted in duplicate numbers. INDs numbered below 14,000 that were submitted to CDER before the consolidation will be assigned new numbers. To determine the new number, CDER has added 80,000 to the original IND number. For example, IND 8,999 will become IND 88,999 and IND 11,192 will become 91,192. INDs that were originally submitted to CBER and transferred to CDER will retain their numbers. FDA has created a Web site with more detailed information here. To view this notice, click here.